Drug Research
Schreiner MediPharm Equips Cap-Lock Security Label with RFID Technology
Schreiner MediPharm, a Germany-based global provider of innovative functional label solutions for the healthcare industry, has enhanced its tamper-evident specialty label, Cap-Lock, with a special...
News
Catalent to Acquire Cell Therapy Manufacturing Facility from Bone Therapeutics
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced...
News
CStone signs pact to out-license ex-Greater China rights for immune checkpoint inhibitors, sugemalimab & CS1003 to EQRx
CStone Pharmaceuticals announced an agreement to out-license ex-Greater China rights for two key late-stage immuno-oncology assets, sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1), to EQRx, a biopharmaceutical...
News
BioInvent licenses anti-Fc?RllB antibody BI-1206 to CASI Pharmaceuticals for Greater China region
BioInvent International AB, a biotechnology company focused on the discovery and development of first-in-class immune-modulatory antibodies for cancer immunotherapy, and CASI Pharmaceuticals, Inc, a U.S....
News
Bayer acquires Asklepios BioPharmaceutical to broaden innovation base in cell and gene therapy
Acquisition fuels Bayer’s cell and gene therapy platform with potential to bring urgently needed treatments to patients across multiple disease areas with high unmet need...
News
Lilly to Supply 300,000 Vials of Neutralizing Antibody Bamlanivimab in an Effort to Fight COVID-19
Eli Lilly and Company announced an initial agreement with the U.S. government to supply 300,000 vials of bamlanivimab (LY-CoV555) 700 mg, an investigational neutralizing antibody,...
News
Integration of Movilitas.Cloud and NiceLabel Simplifies Serialized Label Printing for Highly Regulated Industries
Movilitas today announced the integration of its Movilitas.Cloud with NiceLabel’s cloud-based label printing solution to simplify serialized label printing for highly regulated industries. With 50%...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.